Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Association between glycosylated hemoglobin and intentional weight loss in overweight and obese patients with type 2 diabetes mellitus: a retrospective cohort study.

Shantha GP, Kumar AA, Kahan S, Cheskin LJ.

Diabetes Educ. 2012 May-Jun;38(3):417-26. doi: 10.1177/0145721712443293. Epub 2012 Apr 16.

PMID:
22508341
2.

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes.

Blonde L, Klein EJ, Han J, Zhang B, Mac SM, Poon TH, Taylor KL, Trautmann ME, Kim DD, Kendall DM.

Diabetes Obes Metab. 2006 Jul;8(4):436-47.

PMID:
16776751
3.

Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss.

Jacob S, Rabbia M, Meier MK, Hauptman J.

Diabetes Obes Metab. 2009 Apr;11(4):361-71. doi: 10.1111/j.1463-1326.2008.00970.x. Epub 2009 Jan 22.

PMID:
19207292
4.
6.

Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.

Sánchez-Reyes L, Fanghänel G, Yamamoto J, Martínez-Rivas L, Campos-Franco E, Berber A.

Clin Ther. 2004 Sep;26(9):1427-35.

PMID:
15531005
7.

Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study.

Blicklé JF, Hancu N, Piletic M, Profozic V, Shestakova M, Dain MP, Jacqueminet S, Grimaldi A.

Diabetes Obes Metab. 2009 Apr;11(4):379-86. doi: 10.1111/j.1463-1326.2008.00980.x. Epub 2008 Dec 14.

PMID:
19087105
8.

The impact of self-monitoring of blood glucose on a behavioral weight loss intervention for patients with type 2 diabetes.

McAndrew LM, Napolitano MA, Pogach LM, Quigley KS, Shantz KL, Vander Veur SS, Foster GD.

Diabetes Educ. 2013 May-Jun;39(3):397-405. doi: 10.1177/0145721712449434. Epub 2012 Jun 26. Review.

PMID:
22735195
9.

Diabetes disease stage predicts weight loss outcomes with long-term appetite suppressants.

Khan MA, St Peter JV, Breen GA, Hartley GG, Vessey JT.

Obes Res. 2000 Jan;8(1):43-8.

10.

The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight loss.

Rowe R, Cowx M, Poole C, McEwan P, Morgan C, Walker M.

Curr Med Res Opin. 2005 Nov;21(11):1885-90.

PMID:
16307710
12.
13.

Orlistat in the treatment of overweight or obese Chinese patients with newly diagnosed Type 2 diabetes.

Shi YF, Pan CY, Hill J, Gao Y.

Diabet Med. 2005 Dec;22(12):1737-43.

PMID:
16401321
14.
15.

Intentional weight loss and dose reductions of anti-diabetic medications--a retrospective cohort study.

Kumar AA, Palamaner Subash Shantha G, Kahan S, Samson RJ, Boddu ND, Cheskin LJ.

PLoS One. 2012;7(2):e32395. doi: 10.1371/journal.pone.0032395. Epub 2012 Feb 27.

16.

Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.

Yu AP, Wu EQ, Birnbaum HG, Emani S, Fay M, Pohl G, Wintle M, Yang E, Oglesby A.

Curr Med Res Opin. 2007 Sep;23(9):2157-69. Review.

PMID:
17669232
17.

[Antidiabetic drug therapy in overweight and obese adults with type 2 diabetes].

de Heer J, Parhofer K.

MMW Fortschr Med. 2013 Apr 18;155(7):43-6. Review. German. No abstract available.

PMID:
23668175
18.

Effect of sleeve gastrectomy on patients with diabetes mellitus.

Rosenthal R, Li X, Samuel S, Martinez P, Zheng C.

Surg Obes Relat Dis. 2009 Jul-Aug;5(4):429-34. doi: 10.1016/j.soard.2008.11.006. Epub 2008 Nov 18.

PMID:
19342307
19.

Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein.

Li Z, Hong K, Saltsman P, DeShields S, Bellman M, Thames G, Liu Y, Wang HJ, Elashoff R, Heber D.

Eur J Clin Nutr. 2005 Mar;59(3):411-8.

PMID:
15674301
20.

Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and body mass index <35 kg/m2.

Serrot FJ, Dorman RB, Miller CJ, Slusarek B, Sampson B, Sick BT, Leslie DB, Buchwald H, Ikramuddin S.

Surgery. 2011 Oct;150(4):684-91. doi: 10.1016/j.surg.2011.07.069.

PMID:
22000180

Supplemental Content

Support Center